Legislation


HB 1716 (see companion bill SB 1007) – Maryland

Status: Inactive / Dead
Year Introduced: 2018
Link: http://mgaleg.maryland.gov/webmga/frmMain.aspx?id=hb1716&stab=01&pid=billpage&tab=subject3&ys=2018rs

PRESCRIPTION DRUG MONITORING PROGRAM: Requiring the Prescription Drug Monitoring Program to disclose prescription drug monitoring data, in accordance with certain regulations, to certain insurance carriers for determining the medical necessity of a prescription drug claim, enhancing or coordinating patient care, or assisting the treating provider’s clinical decision making.

Key Issues: PHARMACEUTICALS

Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found

Leave A Comment